主    题：美国专利法的最新发展

主 讲 人：Jasemine Choy Chambers教授
          美国专利商标局政策与对外事务副理事长

主 持 人：刘春田教授
          中国人民大学法学院教授、知识产权学院院长

时    间：3月30日（周三）14:00-16:00

地    点：明德法学楼602

主 办 方：中国人民大学法学院

主讲人简介：
    Jasemine Choy Chambers教授是美国专利商标局政策与对外事务副执行长，其职责是协助政策与对外事务执行长，就知识产权保护和执行、知识产权贸易等事务为美国专利商标局局长提供政策建议。此外，Jasemine Choy Chambers教授还负责美国专利局政策与对外事务办公室的日常运行工作。Jasemine Choy Chambers教授本科毕业于阿格尼斯·斯科特学院生物学专业，在佛罗里达州立大学分子生物物理学博士学位，在乔治华盛顿大学法学院获得法学博士学位。

                        Jasemine Choy Chambers, Ph.D. J.D.
               Deputy Administrator for Policy and External Affairs
                    United States Patent and Trademark Office

As the Deputy Administrator for Policy and External Affairs at the United States Patent and Trademark Office (USPTO), Jasemine assists the Administrator for Policy and External Affairs in providing policy advice to the Under Secretary of Commerce for Intellectual Property and Director of the USPTO on matters relating to intellectual property (IP) protection and enforcement, and IP-related trade issues, including proposed legislation and international activities.  She also has responsibility for overseeing the day to day operations of the Office of Policy and External Affairs that comprises Policy and Administration Support, the Office of Governmental Affairs, the Global IP Academy, the IP Attaché Program, and the Office of the Chief Economist.

Prior to assuming her current position, Jasemine was Director of Technology Center 2900.  She oversaw a 120-member organization responsible for the examination of industrial design patent applications.  Jasemine also participated in the review and analysis of pending legislative proposals on industrial design protection and the implementation of the Geneva Act of the Hague Agreement, as well as represented the USPTO in Trilateral Meetings on Industrial Designs.

Jasemine began her career at the USPTO in 1988 as a Patent Examiner in biotechnology.  She became a Supervisory Patent Examiner in 1996, and was appointed Director of Technology Center 1600 in 2000 to oversee the examination of biotechnology, pharmaceutical, and organic chemistry patent applications.  Jasemine was instrumental in developing policy and practice related to the examination of stem cells, animals and gene therapies, as well as in developing examination guidelines and examiner training materials on the utility, written description and enablement requirements for biotechnological inventions.  She represented the USPTO in meetings of the Trilateral Biotechnology Working Group and worked on harmonizing examination practices.  Jasemine also served as the USPTO's project coordinator in the creation of the Patent Cooperation Treaty Search and Examination Guidelines that was subsequently adopted by the World Intellectual Property Organization in 2004. 

A former law clerk to Chief Judge Randall R. Rader of the U.S. Court of Appeals for the Federal Circuit, Jasemine also has served on detail assignments at the White House Office of Science and Technology Policy, the Department of State’s Office of Intellectual Property Enforcement, and the USPTO’s Office of Intellectual Property Policy and Enforcement.  Prior to joining the USPTO, Jasemine was a Postdoctoral Research Fellow at the Duke University Medical Center, and a Senior Staff Fellow at the National Institutes of Health.

Jasemine is the recipient of a Commerce, Science and Technology Fellowship, a Department of Commerce Team Gold Medal for work on the Patent Cooperation Treaty Search and Examination Guidelines, a Department of Commerce Team Silver Medal for work on China intellectual property issues, two individual Bronze Medals for sustained outstanding performance, and a USPTO Exceptional Career Award. 

Jasemine received a B.A. with high honors in Biology from Agnes Scott College, a Ph.D. in Molecular Biophysics from the Florida State University, and a J.D. with honors from the George Washington University Law School.  She is a member of the Maryland state bar and the District of Columbia bar, and is admitted to practice before the U.S. Supreme Court and the Court of Appeals for the Federal Circuit.